Clinical Trial Update: A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and preliminary anti-tumor activity of Debio 0123 as monotherapy in adults with advanced solid tumors; the trial is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Debio 0123

Snippet

Sponsor: Debiopharm International SA | Conditions: Advanced Solid Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING